IndiaOne Finance - Company Dashboard

Governance Classic Home

Cohance Lifesciences LtdPharmaceuticalsINE03QK01018Consolidated₹438.05-2.30 (-0.52%)Jun-26

Valuation

Market Cap₹16.76K Cr

TTM PE169.77x

Forward PE513.28x

PEG-3.99

Book Value₹102.24

P/B4.28x

TTM EPS₹2.58

Fwd EPS₹0.85

TTM Revenue₹2.14K Cr

TTM PAT₹58.53 Cr

TTM EBITDA₹260.09 Cr

TTM EBIT₹115.30 Cr

Last Qtr PAT₹-45.19 Cr

Last Qtr EBITDA₹1.16 Cr

Last Qtr EBIT₹-48.38 Cr

Profitability

ROE1.50%

ROCE2.92%

TTM NPM2.73%

TTM EBITDA %12.15%

Curr OPM-10.40%

Last OPM1.35%

Curr NPM—

Last NPM—

Curr EPS₹-0.63

Last EPS₹0.51

Balance sheet

Equity₹38.26 Cr

Reserve₹3.87K Cr

Total Debt₹400.49 Cr

D/E0.10x

Interest %-14.91%

Curr Interest₹6.74 Cr

Price / range

Close₹438.00

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.44%

1W-0.44%

1M-3.73%

3M+5.81%

6M+42.99%

1Y-52.09%

2Y-61.74%

3Y-20.97%

5Y—

Diwali-16.33%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	422.26-12.7%	567.55	481.58	497.79	483.58	2,030.50
Other Income	12.25	-0.79	6.12	26.30	13.10	44.73
Total Income	434.51-12.5%	566.76	487.70	524.09	496.68	2,075.23
Interest	6.74	5.17	5.25	5.24	6.80	22.46
Expenditure	-477.38-14.3%	-493.81	-417.41	-403.37	-417.54	-1,732.13
PBDT	0	0	0	0	0	0
EBITDA	1.16-98.9%	116.57	102.78	130.86	104.20	454.41
Depreciation	-49.54	-37.66	-33.36	-31.20	-31.36	-133.58
EBIT	-48.38-166.4%	78.91	69.42	99.66	72.84	320.83
PBT	-42.87-160.3%	56.44	65.43	120.72	71.04	313.63
Tax	-2.32	-21.88	-18.14	-26.43	-18.47	-84.92
Equity	38.26	38.26	0	0	38.26	38.26
OPM	-9.87	9.96	13.59	24.25	14.30	15.11
Net Profit	-45.19-186.0%	34.56	47.29	94.29	52.57	228.71
NPM	-10.40	6.10	9.82	18.94	10.58	11.02
EPS	-0.63-145.7%	0.90	1.24	2.46	1.38	5.98

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	2,030.50+85.7%	1,093.51+6.7%	1,024.99-22.9%	1,330.08
Other Income	44.73	53.98	55.09	44.55
Total Income	2,075.23+80.8%	1,147.49+6.2%	1,080.09-21.4%	1,374.63
Expenditure	-1,732.13-117.6%	-796.14-18.6%	-671.31+15.6%	-795.24
Interest	-22.46	-8	-7.43	-5.39
PBDT	0	0	0	0
EBITDA	454.41+25.3%	362.57-11.5%	409.90-29.7%	583.08
Depreciation	-133.58	-57.20	-48.79	-42.85
EBIT	320.83+5.1%	305.37-15.4%	361.11-33.2%	540.23
PBT	313.63-10.7%	351.35-14.0%	408.77-29.4%	579.39
Tax	-84.92	-79.64	-103.96	-146.79
Equity	38.26	25.46	0	0
OPM (%)	15.11	30.62	38.00	42.00
Net Profit	228.71-15.8%	271.71-10.9%	304.82-29.5%	432.60
NPM (%)	11.02	23.68	28.00	31.00
EPS (Rs)	5.98-44.0%	10.67-10.9%	11.97-29.5%	16.99
CEPS	5.97	10.62	11.97	16.99

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	422.26-23.1%	619.12	544.55	555.57	549.31	2,268.55
Other Income	12.25	-1.84	6.16	15.60	14.17	34.09
Total Income	434.51-22.9%	617.28	550.71	571.17	563.48	2,302.64
Interest	6.74	9.19	0	8.76	10.18	37.24
Expenditure	-477.38+3.1%	-580.86	-505.25	-487.40	-492.62	-2,066.13
PBDT	0	0	0	0	0	0
EBITDA	1.16-99.0%	98.68	39.30	120.95	112.01	426.99
Depreciation	-49.54	-51.23	0	-44.02	-45.14	-187.33
EBIT	-48.38-172.3%	47.45	39.30	76.93	66.87	239.66
PBT	-42.87-168.3%	19.91	40.60	83.77	62.76	207.04
Tax	-2.32	-11.60	-11.58	-17.38	-16.36	-56.92
Equity	38.26	38.26	0	0	38.26	38.26
OPM	-9.87	3.23	7.37	14.67	11.14	8.99
Net Profit	-45.19-197.4%	8.31	29.02	66.39	46.40	150.12
NPM	-10.40	1.35	5.27	11.62	8.23	6.52
EPS	-0.63-149.2%	0.51	0	1.94	1.28	4.69

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	2,268.55+89.4%	1,197.58+13.9%	1,051.35-21.6%	1,340.33
Other Income	34.09	58.56	61.91	46.36
Total Income	2,302.64+83.3%	1,256.14+12.8%	1,113.26-19.7%	1,386.69
Expenditure	-2,066.13-126.5%	-912.22-28.9%	-707.59+14.4%	-826.96
Interest	-37.24	-12.35	-7.45	-5.44
PBDT	0	0	0	0
EBITDA	426.99+13.8%	375.20-7.5%	405.81-28.4%	566.54
Depreciation	-187.33	-77.49	-54.60	-47.73
EBIT	239.66-19.5%	297.71-15.2%	351.21-32.3%	518.81
PBT	207.04-39.8%	343.92-15.2%	405.67-27.5%	559.73
Tax	-56.92	-79.15	-105.39	-148.44
Equity	38.26	25.46	0	0
OPM (%)	8.99	27.38	36.44	40.36
Net Profit	150.12-43.3%	264.77-11.8%	300.28-27.0%	411.29
NPM (%)	6.52	21.08	26.97	29.66
EPS (Rs)	4.69-55.4%	10.52-10.8%	11.80-27.0%	16.16
CEPS	4.68	10.45	11.80	16.16

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split